Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Vikram, B

Published Date

  • February 15, 2001

Published In

Volume / Issue

  • 19 / 4

Start / End Page

  • 1233 - 1234

PubMed ID

  • 11181692

Pubmed Central ID

  • 11181692

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/JCO.2001.19.4.1233

Language

  • eng

Conference Location

  • United States